US Patent

US9504645 — Pharmaceutical formulations for treating ocular conditions

Formulation · Assigned to Oyster Point Pharma Inc · Expires 2035-10-19 · 9y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical formulations for treating ocular conditions.

USPTO Abstract

Described herein are pharmaceutical formulations for treating ocular conditions.

Drugs covered by this patent

varenicline-tartrate (VARENICLINE TARTRATE)

Patent Metadata

Patent number: US9504645
Jurisdiction: US
Classification: Formulation
Expires: 2035-10-19
Drug substance claim: No
Drug product claim: Yes
Assignee: Oyster Point Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.